CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

NCT05512598 ·Status: COMPLETED ·Phase: PHASE1

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares

NCT06013969 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis

NCT06055699 ·Status: NOT_YET_RECRUITING

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

NCT01736696 ·Status: COMPLETED ·Phase: PHASE1

Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis

NCT06610942 ·Status: NOT_YET_RECRUITING

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

NCT05670821 ·Status: COMPLETED

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052 ·Status: COMPLETED ·Phase: PHASE4

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

NCT01519089 ·Status: COMPLETED ·Phase: PHASE3

Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP

NCT05215561 ·Status: COMPLETED

An Exploratory Genetic Study in Participants With Psoriasis

NCT02155192 ·Status: COMPLETED

A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

NCT04399837 ·Status: COMPLETED ·Phase: PHASE2

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

NCT06039189 ·Status: COMPLETED ·Phase: PHASE3

Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis

NCT02978690 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

NCT02326298 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

NCT00111449 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

NCT04053881 ·Status: COMPLETED

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06212999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis

NCT05513014 ·Status: COMPLETED

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

NCT02407041 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

NCT02346240 ·Status: COMPLETED ·Phase: PHASE3

Etanercept Survival in Elderly Population

NCT02503059 ·Status: COMPLETED

Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy

NCT00245765 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients

NCT03149900 ·Status: COMPLETED

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

NCT06231381 ·Status: RECRUITING ·Phase: PHASE2